Clinical trial reportJournal for immunotherapy of cancerPublished
Treatment-free survival and partitioned survival analysis of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib: 5-year update of CheckMate 214
Regional connection
Verified Author affiliations on the Europe PMC record name Fox Chase Cancer Center, Temple Health. Affiliation source
- Institutions
- Fox Chase Cancer Center, Temple Health
- County
- Philadelphia County
Publication record
- Type
- Clinical trial report
- Venue
- Journal for immunotherapy of cancer
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Carcinoma, Renal Cell; Kidney Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Survival Analysis; Adult; Aged; Middle Aged; Female; Male; Ipilimumab; Sunitinib
- PubMed ID
- 39060019
- PubMed Central ID
- PMC11284827
- Open access
- Yes, open
- Added to directory
- Source checked